NASDAQ:HSCS

Heart Test Laboratories Stock News

Healthcare > Medical - Devices

Buy HSCS

*Your capital is at risk

$2.04

-0.0350 (-1.69%)

At Close: Jun 03, 2026

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

08:30am, Tuesday, 19'th May 2026

Agreement follows Cibolo Health's endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences' ECG management platform Ag

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

09:00am, Tuesday, 05'th May 2026

Agreement with St. Vincent Health marks HeartSciences' transition from early adopter installations to commercial SaaS deployments following the full launch of MyoVista Insights at the American College

Analyzing Rennova Health (OTCMKTS:RNVA) & HeartSciences (NASDAQ:HSCS)

02:06am, Monday, 27'th Apr 2026

Rennova Health (OTCMKTS:RNVA - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two business

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

04:15pm, Tuesday, 14'th Apr 2026

Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT”) company focused on

Comparing 10x Genomics (NASDAQ:TXG) and HeartSciences (NASDAQ:HSCS)

01:58am, Friday, 10'th Apr 2026

10x Genomics (NASDAQ: TXG - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based

Hinge Health (NYSE:HNGE) versus HeartSciences (NASDAQ:HSCS) Financial Analysis

04:19am, Thursday, 26'th Mar 2026

HeartSciences (NASDAQ: HSCS - Get Free Report) and Hinge Health (NYSE: HNGE - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based o

HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

08:30am, Wednesday, 25'th Mar 2026

Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focus

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

11:18am, Tuesday, 24'th Mar 2026

Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focuse

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

04:15pm, Monday, 16'th Mar 2026

Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company foc

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

08:30am, Thursday, 05'th Feb 2026

Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advan

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

08:30am, Thursday, 29'th Jan 2026

Southlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by